Literature DB >> 12860525

PI3K and negative regulation of TLR signaling.

Taro Fukao1, Shigeo Koyasu.   

Abstract

Excessive immune responses are detrimental to the host and negative feedback regulation is crucial for the maintenance of immune-system integrity. Recent studies have shown that phosphoinositide 3-kinase (PI3K) is an endogenous suppressor of interleukin-12 (IL-12) production triggered by Toll-like receptor (TLR) signaling and limits excessive Th1 polarization. Unlike IRAK-M (IL-1 receptor-associated kinase-M) and SOCS-1 (suppressor of cytokine signaling-1) that are induced by TLR signaling and function during the second or continuous exposure to stimulation, PI3K functions at the early phase of TLR signaling and modulates the magnitude of the primary activation. Thus, PI3K, IRAK-M and SOCS-1 have unique roles in the gate-keeping system, preventing excessive innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860525     DOI: 10.1016/s1471-4906(03)00139-x

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  208 in total

1.  Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.

Authors:  Kylene Kehn-Hall; Irene Guendel; Lawrence Carpio; Leandros Skaltsounis; Laurent Meijer; Lena Al-Harthi; Joseph P Steiner; Avindra Nath; Olaf Kutsch; Fatah Kashanchi
Journal:  Virology       Date:  2011-04-22       Impact factor: 3.616

2.  B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K.

Authors:  Minjian Ni; Alexander W MacFarlane; Michelle Toft; Clifford A Lowell; Kerry S Campbell; Jessica A Hamerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-20       Impact factor: 11.205

3.  MT1-MMP regulates the PI3Kδ·Mi-2/NuRD-dependent control of macrophage immune function.

Authors:  Ryoko Shimizu-Hirota; Wanfen Xiong; B Timothy Baxter; Steven L Kunkel; Ivan Maillard; Xiao-Wei Chen; Farideh Sabeh; Rui Liu; Xiao-Yan Li; Stephen J Weiss
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

4.  Integrating genetic and gene expression evidence into genome-wide association analysis of gene sets.

Authors:  Qing Xiong; Nicola Ancona; Elizabeth R Hauser; Sayan Mukherjee; Terrence S Furey
Journal:  Genome Res       Date:  2011-09-22       Impact factor: 9.043

5.  Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection.

Authors:  Tavan Janvilisri; Joy Scaria; Yung-Fu Chang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

6.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

7.  Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of β-catenin and FOXO-1.

Authors:  Purnima Gupta; Supriya Srivastav; Shriya Saha; Pijush K Das; Anindita Ukil
Journal:  Cell Death Differ       Date:  2016-09-23       Impact factor: 15.828

8.  Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation.

Authors:  Shi Yue; Jianhua Rao; Jianjun Zhu; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Ling Lu; Xuehao Wang; Yuan Zhai
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

9.  Expression and regulation of alarmin cytokine IL-1α in human retinal pigment epithelial cells.

Authors:  Zong-Mei Bian; Matthew G Field; Susan G Elner; Victor M Elner
Journal:  Exp Eye Res       Date:  2018-03-15       Impact factor: 3.467

10.  Nobiletin-Ameliorated Lipopolysaccharide-Induced Inflammation in Acute Lung Injury by Suppression of NF-κB Pathway In Vivo and Vitro.

Authors:  Weifeng Li; Ruoqi Zhao; Xiumei Wang; Fang Liu; Jinmeng Zhao; Qing Yao; Wenbing Zhi; Zehong He; Xiaofeng Niu
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.